- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
CalciMedica (CALC)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 5.47 mm | 5.47 mm | 5.47 mm | 5.47 mm | 5.47 mm | 5.47 mm |
| Cash burn (monthly) | 149.33 k | 306.75 k | 1.87 mm | 2.08 mm | 1.59 mm | 1.77 mm |
| Cash used (since last report) | 641.06 k | 1.32 mm | 8.04 mm | 8.91 mm | 6.84 mm | 7.62 mm |
| Cash remaining | 4.83 mm | 4.15 mm | -2.57 mm | -3.44 mm | -1.37 mm | -2.15 mm |
| Runway (months of cash) | 32.3 | 13.5 | -1.4 | -1.7 | -0.9 | -1.2 |
| 13F holders | Current |
|---|---|
| Total holders | 36 |
| Opened positions | 9 |
| Closed positions | 6 |
| Increased positions | 8 |
| Reduced positions | 2 |
| 13F shares | Current |
|---|---|
| Total value | 15.03 bn |
| Total shares | 37.04 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Sanderling Venture Partners VI | 24.82 mm | $0.00 |
| Flynn James E | 2.61 mm | $14.64 mm |
| Deerfield Management | 1.30 mm | $4.60 bn |
| BML Investment Partners | 1.24 mm | $921.00 k |
| Soleus Private Equity Fund III | 1.18 mm | $5.64 mm |
| Aisling Capital V | 1.04 mm | $5.84 mm |
| Valence Investments SPV VI | 860.98 k | $3.01 mm |
| Soleus Capital Management | 783.90 k | $2.78 bn |
| Soleus Capital Master Fund | 783.90 k | $4.00 mm |
| Aisling Capital Management | 521.11 k | $1.84 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 13 Oct 25 | Alan Glicklich | Director Stock Option Common Stock | Grant | Acquire A | No | No | 3.26 | 937 | 3.05 k | 937 |
| 18 Sep 25 | Eric W Roberts | Common Stock | Buy | Acquire P | Yes | No | 3.07 | 2,500 | 7.68 k | 84,150 |
| 15 Sep 25 | Eric W Roberts | Common Stock | Buy | Acquire P | Yes | No | 2.6779 | 3,400 | 9.10 k | 81,650 |
| 12 Sep 25 | Eric W Roberts | Common Stock | Buy | Acquire P | Yes | No | 3.12 | 5,000 | 15.60 k | 78,250 |
| 9 Sep 25 | Eric W Roberts | Common Stock | Buy | Acquire P | Yes | No | 3.1488 | 2,343 | 7.38 k | 73,250 |